Antithrombin III
Showing 1 - 25 of 9,909
Antithrombin III Deficiency Trial in Brussel (observation)
Not yet recruiting
- Antithrombin III Deficiency
- observation
-
Brussel, BelgiumUZ Brussel
May 26, 2023
Antithrombin III Deficiency in Adult Patients With ECMO
Completed
- Antithrombin III Deficiency
- Extracorporeal Membrane Oxygenation Complication
- Antithrombin III
-
Istanbul, TurkeyIstanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Tra
May 22, 2022
Acquired Antithrombin Deficiency Trial (Human plasma derived antithrombin, Placebo)
Not yet recruiting
- Acquired Antithrombin Deficiency
- Human plasma derived antithrombin
- Placebo
- (no location specified)
Oct 17, 2023
Antithrombin III Treatment in Severe COVID-19 Infection
Active, not recruiting
- Covid19
- Antithrombin III
-
Innsbruck, Austria
- +5 more
Aug 1, 2022
Portal Vein Thrombosis, Cirrhosis, Liver Trial in Hershey (Antithrombin III, Placebo)
Withdrawn
- Portal Vein Thrombosis
- Cirrhosis, Liver
- Antithrombin III
- Placebo
-
Hershey, PennsylvaniaPenn State College of Medicine
Feb 23, 2022
Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)
Active, not recruiting
- Antithrombin III Deficiency
- Plasma-derived AT-III concentrate
- (no location specified)
May 5, 2022
Liver Transplantation and Antithrombin Trial in Seoul (Antithrombin III)
Completed
- Liver Transplantation and Antithrombin
- Antithrombin III
-
Seoul, Korea, Republic ofAsan Medical Center
May 30, 2021
Congenital Antithrombin Deficiency Trial in Worldwide (Atenativ)
Recruiting
- Congenital Antithrombin Deficiency
-
Washington, District of Columbia
- +13 more
Sep 16, 2022
Hepatic Veno-Occlusive Disease Trial in Seoul (Freeze-dried Concentrated Human Antithrombin ? 500 IU)
Active, not recruiting
- Hepatic Veno-Occlusive Disease
- Freeze-dried Concentrated Human Antithrombin Ⅲ 500 IU
-
Seoul, Chongno-gu, Korea, Republic ofSeoul National University Hospital
Mar 28, 2021
Antithrombin Deficiency in Patients of Intensive Care Unit
Completed
- Severe Cardiac Insufficiency
- Blood sample
-
Rennes, FranceCHU Rennes
Jun 3, 2021
Raloxifene, Postmenopausal Women Trial (coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S,
Completed
- Raloxifene
- Postmenopausal Women
- coagulation system parameters; factor 8, von Willebrand factor, protein C, protein S, antithrombin III and fibrinogen were studied.
- (no location specified)
Jul 2, 2020
ATIII Deficiency Trial in Durham (Anti-thrombin III, Placebo)
Completed
- ATIII Deficiency
- Anti-thrombin III
- Placebo
-
Durham, North CarolinaDuke University
Nov 21, 2019
Hemophilia A Trial (Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin
Not yet recruiting
- Hemophilia A
- Fitusiran (SAR439774)
- +3 more
- (no location specified)
Nov 17, 2023
Hemophilia Trial in Orange (Fitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate
Recruiting
- Hemophilia
- Fitusiran
- +2 more
-
Orange, CaliforniaCenter for Inherited Blood Disorders (CIBD)-Site Number:8400012
Feb 2, 2023
Reperfusion Injury Trial in Leuven (Antithrombin-III, Infliximab, Apotransferrin)
Completed
- Reperfusion Injury
- Antithrombin-III
- +9 more
-
Leuven, BelgiumUniversity Hospitals Leuven
Aug 8, 2019
Extracorporeal Membrane Oxygenation Complication, Cardiopulmonary Bypass Trial in Cincinnati (Antithrombin III)
Completed
- Extracorporeal Membrane Oxygenation Complication
- Cardiopulmonary Bypass
- Antithrombin III
-
Cincinnati, OhioCincinnati Childrens Hospital Medical Center
Jan 24, 2019
Smoking, Weak Association With Thrombophilia
Completed
- Livedoid Vasculitis
- Thrombophilia screening
-
Basel, Switzerland
- +2 more
May 17, 2023
Blood Coagulation Profile After Liver Resection.
Not yet recruiting
- Coagulation Disorder
- thromboelastography (TEG®6s)
- (no location specified)
Apr 11, 2023
Transfusion Practice in Vv-ECMO Patients: The PROTECMO Study
Completed
- Extracorporeal Membrane Oxygenation Complication
- +3 more
-
Palermo, ItalyIsmett
Sep 10, 2021
A Practical Nomogram Based on Systemic Inflammatory Markers for
Completed
- Systemic Inflammatory Markers
- Portal Vein Thrombosis
- clinical laboratory tests, and imaging characteristics
-
Qingdao, Shandong, Chinathe Affiliated Hospital of Qingdao University
Sep 13, 2022
Preeclampsia Trial in Japan (Antithrombin gamma, physiological saline)
Recruiting
- Preeclampsia
- Antithrombin gamma
- physiological saline
-
Nagoya, Aichi, Japan
- +62 more
Nov 16, 2022
Migraine With Aura and Patent Foramen Ovale: Identification of
Recruiting
- Migraine Headache
- PFO - Patent Foramen Ovale
- blood samples collection
-
San Donato Milanese, Milan, Italy
- +2 more
Sep 12, 2023
Covid19, Severe Acute Respiratory Syndrome, Distress Respiratory Syndrome Trial in Córdoba (Antithrombin + best available
Completed
- Covid19
- +2 more
- Antithrombin + best available treatment
- Best available treatment
-
Córdoba, SpainHospital Universitario Reina Sofía
Feb 8, 2021
Disseminated Intravascular Coagulation Trial (Antithrombin alfa (INN name), Control (Standard treatment))
Terminated
- Disseminated Intravascular Coagulation
- Antithrombin alfa (INN name)
- Control (Standard treatment)
- (no location specified)
Aug 5, 2021